Encouraging prospects with sugemalimab in relapsed or refractory extranodal natural killer/T-cell lymphoma.
Chin Clin Oncol
; 13(1): 17, 2024 Feb.
Article
in En
| MEDLINE
| ID: mdl-38073311
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Lymphoma, T-Cell
/
Lymphoma, Extranodal NK-T-Cell
/
Antibodies, Monoclonal, Humanized
Limits:
Humans
Language:
En
Journal:
Chin Clin Oncol
Year:
2024
Document type:
Article
Affiliation country:
United States
Country of publication:
China